Efficacy and Safety of Mycophenolate Mofetil for Lichen Planopilaris

    Bryan K. Cho, Deborah Sah, Jennifer Chwalek, Ingrid E. Roseborough, Blanca Ochoa, Charles Chiang, Vera H. Price
    Image of study
    TLDR Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.
    In a retrospective study from 2003 to 2007, mycophenolate mofetil (MMF) was found to be effective in 83% of the patients (10 out of 12) for treating lichen planopilaris (LPP), a condition associated with scarring hair loss. The study included 16 adult patients, but only 12 completed the treatment, with 5 achieving complete response and 5 showing partial response based on the Lichen Planopilaris Activity Index (LPPAI). The treatment was deemed effective with a significant decrease in LPPAI scores (P < .005). However, 4 patients withdrew due to adverse events, and the study's limitations included its retrospective nature and small sample size.
    View this study on jaad.org → Discuss this study in the Community →

    Related

    6 / results